Lv12
20 积分 2024-01-29 加入
New advances in oral microbiology and tumor research
19小时前
待确认
Renal dysfunction during osimertinib treatment in patients with non–small cell lung cancer positive for EGFR mutations
20小时前
已完结
Case report of short term EGFR TKI induced tubulointerstitial nephritis and IgA nephropathy in a patient with advanced non small cell lung cancer
20小时前
已完结
Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
20小时前
已完结
P1.12B.09 Efficacy of Selpercatinib by RET Fusion Partner in RET+ NSCLC: Results from the LIBRETTO-001 and LIBRETTO-431 Trials
10天前
已关闭
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
25天前
已完结
Complete Response and Survival Outcomes in Patients with Advanced Cancer on Immune Checkpoint Inhibitors
25天前
已完结
Real-world outcomes in patients with KRAS G12C–mutated advanced non-small cell lung cancer treated with docetaxel in second-line or beyond
25天前
已完结
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients
1个月前
已完结
Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Interstitial Lung Diseases: A Systematic Review and Meta-Analysis
1个月前
已完结
皖公网安备34019202002308
